The DOI matches its Crossref record, with a small difference in title or year; 37 of the 38 references it cites were found in a registry or an index.
Net Clinical Benefit of Warfarin in Patients With Atrial Fibrillation: A Report From the Swedish Atrial Fibrillation Cohort Study
Open accessAbstract
Background—: Known risk factors for bleeding during anticoagulant treatment are largely the same as those predicting thromboembolic events in patients with atrial fibrillation (AF). Our objective was to investigate how to maximize the likelihood of avoiding both stroke and bleeding. Methods and Results—: All 182 678 subjects with atrial fibrillation in the Swedish Hospital Discharge Register were studied for an average of 1.5 years (260 000 patient-years at risk). Patients were stratified according to risk scores with the use of historic International Classification of Disease diagnostic codes in the register. Information about medication was obtained from the Swedish Drug Registry. Our primary end point was net benefit defined as number of avoided ischemic strokes with anticoagulation minus the number of excess intracranial bleedings with a weight of 1.5 to compensate for the generally more severe outcome with intracranial bleedings. The adjusted net clinical benefit favored anticoagulation for almost all atrial fibrillation patients. The exceptions were patients at very low risk of ischemic stroke with a CHA 2 DS 2 -VASc score of 0 and moderately elevated bleeding risk (−1.7%/y). The results were broadly similar with CHADS 2 , except for patients with very low embolic risk; the CHA 2 DS 2 -VASc was able to identify those patients (n=6205, 3.9% of all patients) who had no net clinical benefit or even some disadvantage from anticoagulant treatment. Conclusions—: In almost all patients with atrial fibrillation, the risk of ischemic stroke without anticoagulant treatment is higher than the risk of intracranial bleeding with anticoagulant treatment. Analysis of the net benefit indicates that more patients may benefit from anticoagulant treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“initial uptake of the intervention was 99.4%”
From Accuracy requirements for cost-effective suicide risk prediction among primary care patients in the US (2021) · cites this paper as [30]
In the citing paper
“These factors resulted in a total health care cost of $96”
From Accuracy requirements for cost-effective suicide risk prediction among primary care patients in the US (2021) · cites this paper as [30]
In the citing paper
“this issue was addressed by instead performing a thorough cost accounting from 2 specific exemplar interventions.30,31”
From Accuracy requirements for cost-effective suicide risk prediction among primary care patients in the US (2021) · cites this paper as [30]
Citations
Cites
Dabigatran versus warfarin in patients with atrial fibrillation
Connolly, S. J., Ezekowitz, M. D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., Pogue, J., Reilly, P. A., Themeles, E., Varrone, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905561 · Cited by 11,215
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
Patel, M. R., Mahaffey, K. W., Garg, J., Pan, G., Singer, D. E., Hacke, W., Breithardt, G., Halperin, J. L., Hankey, G. J., Piccini, J. P., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009638 · Cited by 9,430
Apixaban versus warfarin in patients with atrial fibrillation
Granger, C. B., Alexander, J. H., McMurray, J. J. V., Lopes, R. D., Hylek, E. M., Hanna, M., Al-Khalidi, H. R., Ansell, J., Atar, D., Avezum, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1107039 · Cited by 8,943
Lip, G. Y. H., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. G. M. (2010) · Chest · doi:10.1378/chest.09-1584 · Cited by 6,879
Self-citationGuidelines for the management of atrial fibrillation
Authors/Task Force Members, Camm, A. J., Kirchhof, P. F., Lip, G. Y. H., Schotten, U., Savelieva, I., Ernst, S., Gelder, I. C. V., Al‐Attar, N., Hindricks, G., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq278 · Cited by 5,924
Self-citationExternal review and validation of the Swedish national inpatient register
Ludvigsson, J. F., Andersson, E., Ekbom, A., Feychting, M., Kim, J.-L., Reuterwall, C., Heurgren, M., & Olausson, P. O. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-450 · Cited by 5,055
Gage, B. F., Waterman, A. D., Shannon, W., Boechler, M., Rich, M. W., & Radford, M. J. (2001) · JAMA · doi:10.1001/jama.285.22.2864 · Cited by 4,832
Hart, R. G., Pearce, L. A., & Aguilar, M. I. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-12-200706190-00007 · Cited by 4,793
Pisters, R., Lane, D. A., Nieuwlaat, R., de Vos, C. B., Crijns, H. J. G. M., & Lip, G. Y. H. (2010) · CHEST Journal · doi:10.1378/chest.10-0134 · Cited by 4,517
Self-citationApixaban in patients with atrial fibrillation
Connolly, S. J., Eikelboom, J., Joyner, C., Diener, H.-C., Hart, R., Golitsyn, S., Flaker, G., Avezum, A., Hohnloser, S. H., Diaz, R., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1007432 · Cited by 2,483 · cited 3×
“Frequent falls, n (%) 9294 (10) 2647 (4) 0.”
Self-citation
Flagged first, then by citations
1 of the 38 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- 10.1001/archinte.1996.00440040081009 · DOI
Cited by
Sorted by citations
2012 focused update of the ESC Guidelines for the management of atrial fibrillation
Authors Task Force Members, Camm, A. J., Lip, G. Y. H., Caterina, R. D., Savelieva, I., Atar, D., Hohnloser, S. H., Hindricks, G., Kirchhof, P. F., Bax, J. J., et al. (2012) · EP Europace · doi:10.1093/europace/eus305 · Cited by 3,823
Self-citationJoglar, J. A., Chung, M. K., Armbruster, A. L., Benjamin, E. J., Chyou, J. Y., Cronin, E. M., Deswal, A. M., Eckhardt, L. L., Goldberger, Z. D., Gopinathannair, R., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001193 · Cited by 3,072
2012 focused update of the ESC Guidelines for the management of atrial fibrillation
Authors Task Force Members, Camm, A. J., Lip, G. Y. H., Caterina, R. D., Savelieva, I., Atar, D., Hohnloser, S. H., Hindricks, G., Kirchhof, P. F., Bax, J. J., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs253 · Cited by 2,929
Self-citationEpidemiology of atrial fibrillation: European perspective
Zoni-Berisso, M., Lercari, F., Carazza, T., & Domenicucci, S. (2014) · Clinical Epidemiology · doi:10.2147/clep.s47385 · Cited by 1,275
Campbell, B. C. V., & Khatri, P. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31179-x · Cited by 1,197
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation
Joglar, J. A., Chung, M. K., Armbruster, A. L., Benjamin, E. J., Chyou, J. Y., Cronin, E. M., Deswal, A., Eckhardt, L. L., Goldberger, Z. D., Gopinathannair, R., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.08.017 · Cited by 933
The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation
O'Brien, E. C., Simon, D. N., Thomas, L. E., Hylek, E. M., Gersh, B. J., Ansell, J., Kowey, P. R., Mahaffey, K. W., Chang, P., Fonarow, G. C., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv476 · Cited by 449
Vitamin K antagonists in heart disease: Current status and perspectives (Section III)
Husted, S., Wallentin, L. C., Andreotti, F., Arnesen, H., Bachmann, F., Baigent, C., Huber, K., Jespersen, J., Kristensen, S. D., Lip, G. Y. H., et al. (2013) · Thrombosis and Haemostasis · doi:10.1160/th13-06-0443 · Cited by 373
Self-citationParenteral anticoagulants in heart disease: Current status and perspectives (Section II)
Husted, S., Wallentin, L. C., Andreotti, F., Arnesen, H., Bachmann, F., Baigent, C., Huber, K., Jespersen, J., Kristensen, S. D., Lip, G. Y. H., et al. (2013) · Thrombosis and Haemostasis · doi:10.1160/th12-06-0403 · Cited by 366
Self-citationStroke Prevention in Atrial Fibrillation
Lip, G. Y. H., & Lane, D. A. (2015) · JAMA · doi:10.1001/jama.2015.4369 · Cited by 336
Self-citationHsu, J. C., Maddox, T. M., Kennedy, K. F., Katz, D. F., Marzec, L., Lubitz, S. A., Gehi, A. K., Turakhia, M. P., & Marcus, G. M. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2015.0374 · Cited by 302
Atrial fibrillation prevalence revisited
Friberg, L., & Bergfeldt, L. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12114 · Cited by 256
Self-citation2020 Clinical guidelines for Atrial fibrillation and atrial flutter
Arakelyan, M. S., Bockeria, L. A., Vasilieva, E., Sp, G., Golukhova, E. Z., Gorev, M. V., Davtyan, K. V., Drapkina, O. M., Станиславовна, К. Е., Kuchinskaya, Е. А., et al. (2021) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2021-4594 · Cited by 258
The Epidemiology of Atrial Fibrillation and Stroke
Pistoia, F., Sacco, S., Tiseo, C., Degan, D., Ornello, R., & Carolei, A. (2016) · Cardiology Clinics · doi:10.1016/j.ccl.2015.12.002 · Cited by 244
Andreotti, F., Rocca, B., Husted, S., Ajjan, R., ten Berg, J. M., Cattaneo, M., Collet, J., Caterina, R. D., Fox, K. A. A., Halvorsen, S., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv304 · Cited by 239
Self-citationLip, G. Y. H., Coca, A., Kahan, T., Boriani, G., Manolis, A. S., Olsen, M. H., Oto, A., Potpara, T., Steffel, J., Marín, F. R., et al. (2017) · EP Europace · doi:10.1093/europace/eux091 · Cited by 233
Self-citationHankey, G. J., Stevens, S. R., Piccini, J. P., Lokhnygina, Y. V., Mahaffey, K. W., Halperin, J. L., Patel, M. R., BREITHARDT, G. E., Singer, D. E., Becker, R. C., et al. (2014) · Stroke · doi:10.1161/strokeaha.113.004506 · Cited by 215
Friberg, L., Skeppholm, M., & Terént, A. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.10.052 · Cited by 207
Self-citationGallego, P., Roldan, V., Marín, F., Romera, M., Valdés, M., Vicente, V., & Lip, G. Y. H. (2013) · Thrombosis and Haemostasis · doi:10.1160/th13-07-0556 · Cited by 187
Self-citationAn Update on the Prognosis of Patients With Atrial Fibrillation
McManus, D. D., Rienstra, M., & Benjamin, E. J. (2012) · Circulation · doi:10.1161/circulationaha.112.129759 · Cited by 178
Lip, G. Y. H., Skjøth, F., Rasmussen, L. H., & Larsen, T. B. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.01.044 · Cited by 171
Self-citationLip, G. Y. H., Wang, K.-L., & Chiang, C. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.11.182 · Cited by 162
Self-citationStroke and bleeding risk assessment in atrial fibrillation: when, how, and why?
Lip, G. Y. H. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs435 · Cited by 161
Self-citationSafety and efficacy of well managed warfarin
Sjögren, V., Grzymala-Lubanski, B., Renlund, H., Friberg, L., Lip, G. Y. H., Svensson, P. J., & Själander, A. (2015) · Thrombosis and Haemostasis · doi:10.1160/th14-10-0859 · Cited by 145
Self-citationKirchhof, P., Breithardt, G., Aliot, E., Al Khatib, S., Apostolakis, S., Auricchio, A., Bailleul, C., Bax, J., Benninger, G., Blomstrom-Lundqvist, C., et al. (2013) · Europace · doi:10.1093/europace/eut232 · Cited by 141
Self-citationNovel genetic markers improve measures of atrial fibrillation risk prediction
Everett, B. M., Cook, N. R., Conen, D., Chasman, D. I., Ridker, P. M., & Albert, C. M. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht033 · Cited by 141
Chiang, C., Wu, T.-J., Ueng, K.-C., Chao, T., Chang, K., Wang, C.-C., Lin, Y., Yin, W., Kuo, J., Lin, W., et al. (2016) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2016.10.005 · Cited by 138
Senoo, K., Proietti, M., Lane, D. A., & Lip, G. Y. H. (2015) · The American Journal of Medicine · doi:10.1016/j.amjmed.2015.10.001 · Cited by 128
Self-citationKalarus, Z. F., Mairesse, G. H., Sokal, A., Boriani, G., Średniawa, B., Casado-Arroyo, R., Wachter, R., Frommeyer, G., TRAYKOV, V. B., Dagres, N., et al. (2022) · EP Europace · doi:10.1093/europace/euac144 · Cited by 122
Self-citationO'Brien, E. C., Simon, D. N., Allen, L. A., Singer, D. E., Fonarow, G. C., Kowey, P. R., Thomas, L. E., Ezekowitz, M. D., Mahaffey, K. W., Chang, P., et al. (2014) · American Heart Journal · doi:10.1016/j.ahj.2014.07.002 · Cited by 121
Guo, Y., Lane, D. A., Chen, Y., & Lip, G. Y. H. (2020) · The American Journal of Medicine · doi:10.1016/j.amjmed.2020.03.019 · Cited by 119
Self-citationLip, G. Y. H., & Lane, D. A. (2016) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13386 · Cited by 117
Self-citationStroke risk assessment in atrial fibrillation: risk factors and markers of atrial myopathy
Calenda, B. W., Fuster, V., Halperin, J. L., & Granger, C. B. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.106 · Cited by 117
Risk of stroke and intracranial hemorrhage in 9727 Chinese with atrial fibrillation in Hong Kong
Siu, C., Lip, G. Y. H., Lam, K., & Tse, H. (2014) · Heart Rhythm · doi:10.1016/j.hrthm.2014.04.021 · Cited by 114
Self-citationYoon, M., Yang, P., Jang, E., Yu, H. J., Kim, T., Uhm, J., Kim, J., Pak, H., Lee, M., Lip, G. Y. H., et al. (2018) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1651482 · Cited by 113
Self-citationSkjøth, F., Nielsen, P., Larsen, T. B., & Lip, G. (2015) · Thrombosis and Haemostasis · doi:10.1160/th15-07-0565 · Cited by 106
Self-citationApostolakis, S. Z., Lane, D. A., Buller, H. R., & Lip, G. Y. H. (2013) · Thrombosis and Haemostasis · doi:10.1160/th13-07-0552 · Cited by 107
Self-citationIschemic Stroke Risk in Patients With Atrial Fibrillation and CHA 2 DS 2 -VASc Score of 1
Joundi, R. A., Cipriano, L. E., Sposato, L. A., & Saposnik, G. (2016) · Stroke · doi:10.1161/strokeaha.115.012609 · Cited by 106
Chao, T., Lip, G. Y. H., Liu, C., Tuan, T., Chen, S., Wang, K.-L., Lin, Y., Chang, S., Lo, L., Hu, Y., et al. (2016) · Stroke · doi:10.1161/strokeaha.116.013880 · Cited by 106
Self-citationChristersson, C., Wallentin, L. C., Andersson, U., Alexander, J. H., Ansell, J., Caterina, R. D., Gersh, B. J., Granger, C. B., Hanna, M., Horowitz, J. D., et al. (2014) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12638 · Cited by 103
Anticoagulation in atrial fibrillation
Steinberg, B. A., & Piccini, J. P. (2014) · BMJ · doi:10.1136/bmj.g2116 · Cited by 104
Long-term antithrombotic treatment in intracranial hemorrhage survivors with atrial fibrillation
Korompoki, E., Filippidis, F. T., Nielsen, P. B., Giudice, A. D., Lip, G. Y. H., Kuramatsu, J. B., Huttner, H. B., Fang, J., Schulman, S., Martí‐Fábregas, J., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004235 · Cited by 102
Self-citationFriberg, L., Engdahl, J., Frykman, V., Svennberg, E., Levin, L.-Å., & Rosenqvist, M. (2013) · EP Europace · doi:10.1093/europace/eus217 · Cited by 100
Self-citationIschemic Stroke and Intracranial Hemorrhage With Aspirin, Dabigatran, and Warfarin
Ho, C. W., Ho, M.-H., Chan, P., Hai, J. J., Cheung, E. H.-L., Yeung, C., Lau, K. K., Chan, K., Lau, C., Lip, G. Y. H., et al. (2014) · Stroke · doi:10.1161/strokeaha.114.006476 · Cited by 95
Self-citationOutcomes of Direct Oral Anticoagulants in Patients With Mitral Stenosis
Kim, J. Y., Kim, S., Myong, J., Kim, Y. R., Kim, T., Kim, J., Jang, S.-W., Oh, Y., Lee, M. Y., & Rho, T. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.12.047 · Cited by 93
Westenbrink, B. D., Alings, M., Granger, C. B., Alexander, J. H., Lópes, R. D., Hylek, E. M., Thomas, L. E., WOJDYLA, D. M., Hanna, M., Keltai, M., et al. (2016) · American Heart Journal · doi:10.1016/j.ahj.2016.12.008 · Cited by 91
Atrial Fibrillation in Older People: Concepts and Controversies
Zathar, Z., Karunatilleke, A., Fawzy, A. M., & Lip, G. Y. H. (2019) · Frontiers in Medicine · doi:10.3389/fmed.2019.00175 · Cited by 94
Self-citationSteinberg, B. A., Greiner, M. A., Hammill, B. G., Curtis, L. H., Benjamin, E. J., Heckbert, S. R., & Piccini, J. P. (2015) · Cardiovascular Therapeutics · doi:10.1111/1755-5922.12129 · Cited by 91
Rohla, M., Weiss, T. W., Pecen, L., Patti, G., Siller-Matula, J. M., Schnabel, R. B., SCHILLING, R. J., Kotecha, D., Lucerna, M., Huber, K., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-022478 · Cited by 84
Ogawa, S., Aonuma, K., Tse, H., Huang, D., Huang, J., Kalman, J. M., Kamakura, S., Nair, M., Shin, D., Stiles, M. K., et al. (2013) · Journal of Arrhythmia · doi:10.1016/j.joa.2013.03.002 · Cited by 83
Risks and Benefits of Anticoagulation in Atrial Fibrillation
Cullen, M. W., Kim, S., Piccini, J. P., Ansell, J., Fonarow, G. C., Hylek, E. M., Singer, D. E., Mahaffey, K. W., Kowey, P. R., Thomas, L. E., et al. (2013) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.113.000127 · Cited by 83
Forslund, T., Wettermark, B., Wändell, P. E., von Euler, M., Hasselström, J., & Hjemdahl, P. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.10.063 · Cited by 82
Antithrombotic therapy for stroke prevention in non-valvular atrial fibrillation
Alberts, M. J., Eikelboom, J. W., & Hankey, G. J. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70258-2 · Cited by 80
Chao, T., Lip, G. Y. H., Lin, Y., Chang, S., Lo, L., Hu, Y., Tuan, T., Liao, J., Chung, F., Chen, T., et al. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.11.025 · Cited by 78
Self-citationWestenbrink, B. D., Alings, M., Connolly, S. J., Eikelboom, J. W., Ezekowitz, M. D., Oldgren, J., Yang, S., Pongue, J., Yusuf, S., Wallentin, L. C., et al. (2015) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12874 · Cited by 78
Left atrial appendage occlusion: rationale, evidence, devices, and patient selection
Piccini, J. P., Sievert, H., & Patel, M. R. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw330 · Cited by 73
Skeppholm, M., Al-Aieshy, F., Berndtsson, M., Al‐Khalili, F., Rönquist-Nii, Y., Söderblom, L., Östlund, A., Pohanka, A., Antović, J. P., & Malmström, R. E. (2015) · Thrombosis Research · doi:10.1016/j.thromres.2015.04.030 · Cited by 73
How to choose appropriate direct oral anticoagulant for patient with nonvalvular atrial fibrillation
Schaefer, J. K., McBane, R. D., & Wysokiński, W. E. (2015) · Annals of Hematology · doi:10.1007/s00277-015-2566-x · Cited by 71
Effect of Genetic Variants, Especially CYP2C9 and VKORC1, on the Pharmacology of Warfarin
Patsopoulos, N. A., Belknap, S. M., O’Rourke, D. J., Robb, J. F., Anderson, J. L., Shworak, N. W., Moore, J. H., & Fung, E. (2012) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0032-1328891 · Cited by 69
Andersson, T., Magnuson, A., Bryngelsson, I.-L., Frøbert, O., Henriksson, K. M., Edvardsson, N., & Poçi, D. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.09.092 · Cited by 68
Major bleeding with vitamin K antagonist anticoagulants in pulmonary hypertension
Henkens, I. R., Hazenoot, T., Boonstra, A., Huisman, M. V., & Noordegraaf, A. V. (2012) · European Respiratory Journal · doi:10.1183/09031936.00039212 · Cited by 68
Puurunen, M. K., Kiviniemi, T., Schlitt, A., Rubboli, A., Dietrich, B., Karjalainen, P. P., Nyman, K., Niemelä, M. J., Lip, G. Y. H., & Airaksinen, J. K. E. (2014) · Thrombosis Research · doi:10.1016/j.thromres.2014.01.007 · Cited by 67
Self-citationAn update on atrial fibrillation in 2014: From pathophysiology to treatment
Ferrari, R., Bertini, M., Blomström‐Lundqvist, C., Dobrev, D., Kirchhof, P. F., Pappone, C., Ravens, U., Tamargo, J. L., Tavazzi, L., & Vicedomini, G. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.10.089 · Cited by 67
Ross, E. L., Zuromski, K. L., Reis, B. Y., Nock, M. K., Kessler, R. C., & Smoller, J. W. (2021) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2021.0089 · Cited by 65
Quon, M. J., Behlouli, H., & Pilote, L. (2017) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2017.08.003 · Cited by 65
Risks and benefits of clopidogrel–aspirin in minor stroke or TIA
Pan, Y., Jing, J., Chen, W., Meng, X., Li, H., Zhao, X., Liu, L., Wang, D., Johnston, S. C., Wang, Y., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000003941 · Cited by 63
Acute, periprocedural and longterm antithrombotic therapy in older adults
Andreotti, F., Geisler, T., Collet, J., Gigante, B., Gorog, D. A., Halvorsen, S., Lip, G. Y. H., Morais, J., Navarese, E. P., Patrono, C., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac515 · Cited by 64
Self-citationBahit, M. C., Lópes, R. D., WOJDYLA, D. M., Hohnloser, S. H., Alexander, J. H., Lewis, B. S., Aylward, P. E., Verheugt, F. W. A., Keltai, M., Díaz, R., et al. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.10.062 · Cited by 63
Franchini, M., Mengoli, C., Cruciani, M., Bonfanti, C., & Mannucci, P. M. (2014) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12647 · Cited by 60
Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation
Shah, S. J., Singer, D. E., Fang, M. C., Reynolds, K., Go, A. S., & Eckman, M. H. (2019) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.119.006212 · Cited by 60
Stroke risk in atrial fibrillation: Do we anticoagulate CHADS2 or CHA2DS2-VASc ≥1, or higher?
Olesen, J. B., & Torp-Pedersen, C. T. (2015) · Thrombosis and Haemostasis · doi:10.1160/th15-02-0154 · Cited by 59
Lauer, A., Pfeilschifter, W., Schaffer, C. B., Lo, E. H., & Foerch, C. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70049-8 · Cited by 60
Sulzgruber, P., Waßmann, S., Semb, A. G., Doehner, W., Widimský, P., Gremmel, T., Kaski, J. C., Savarese, G., Rosano, G. M. C., Borghi, C., et al. (2019) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvz016 · Cited by 58
Patterns of multimorbidity and pharmacotherapy: a total population cross-sectional study
Forslund, T., Carlsson, A. C., Ljunggren, G., Ärnlöv, J., & Wachtler, C. (2020) · Family Practice · doi:10.1093/fampra/cmaa056 · Cited by 58
Dzeshka, M. S., Lane, D. A., & Lip, G. Y. H. (2014) · Clinical Cardiology · doi:10.1002/clc.22294 · Cited by 57
Self-citationPotpara, T., Dan, G., Trendafilova, E., Goda, A., Kušljugić, Z., Manola, Š., Musić, L., Musetescu, R., Bădilă, E., Mitic, G. P., et al. (2016) · Scientific Reports · doi:10.1038/srep20432 · Cited by 57
Self-citationA cost-effectiveness analysis of screening for silent atrial fibrillation after ischaemic stroke
Levin, L.-A., Husberg, M., Sobocinski, P. D., Kull, V. F., Friberg, L., Rosenqvist, M., & Davidson, T. (2015) · Europace · doi:10.1093/europace/euu213 · Cited by 56
Self-citationNet Clinical Benefit of Warfarin Therapy in Elderly Chinese Patients With Atrial Fibrillation
Siu, C., & Tse, H. (2014) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.113.000858 · Cited by 56
Chan, P., Huang, D., Yip, P.-S., Hai, J. J., Tse, H., Chan, T. M., Lip, G. Y. H., Lo, W.-K., & Siu, C. (2015) · EP Europace · doi:10.1093/europace/euv289 · Cited by 55
Self-citationArchibald, W. J., Rabe, K. G., Kabat, B., Herrmann, J., Ding, W., Kay, N. E., Kenderian, S. S., Muchtar, E., Leis, J. F., Wang, Y., et al. (2020) · Annals of Hematology · doi:10.1007/s00277-020-04094-3 · Cited by 55
Yiin, G. S. C., Howard, D. P. J., Paul, N. L. M., Li, L., Mehta, Z., & Rothwell, P. M. (2015) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2015-311947 · Cited by 53
Russo, V., Carbone, A., Attena, E., Rago, A., Mazzone, C., Proietti, R., Parisi, V., Scotti, A., Nigro, G., Golino, P., et al. (2019) · Clinical Therapeutics · doi:10.1016/j.clinthera.2019.10.008 · Cited by 53
Yasaka, M., & Lip, G. Y. H. (2014) · Circulation Journal · doi:10.1253/circj.cj-14-0720 · Cited by 53
Self-citationOral Anticoagulant Therapy in Atrial Fibrillation Patients at High Stroke and Bleeding Risk
Potpara, T., & Lip, G. Y. H. (2015) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2015.07.003 · Cited by 52
Self-citationThe risks of risk scores for stroke risk assessment in atrial fibrillation
Chao, T., & Nielsen, P. B. (2015) · Thrombosis and Haemostasis · doi:10.1160/th15-03-0210 · Cited by 50
Komen, J. J., Pottegård, A., Mantel-Teeuwisse, A. K., Forslund, T., Hjemdahl, P., Wettermark, B., Hallas, J., Olesen, M. S., Bennie, M., Mueller, T., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac111 · Cited by 50
Perioperative challenges of atrial fibrillation
Philip, I., Berroëta, C., & Leblanc, I. (2014) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000000070 · Cited by 50
Comorbidity of patients with noncommunicable diseases in general practice. Eurasian guidelines
Drapkina, O. M., Васильевна, К. А., Калинина, А. М., Avdeev, S. N., Викторович, А. М., Алексеева, Л. И., Almazova, I. I., Andreenko, Е. Y., Antipushina, D. N., Balanova, Y. А., et al. (2024) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2024-3996 · Cited by 55
II Diretrizes Brasileiras de Fibrilação Atrial
Magalhães, L., Figueiredo, M., Cintra, F., Eb, S., Kuniyoshi, R. R., Teixeira, R., Filho, A. L., d’Ávila, A., de Paola, A., Kalil, C., et al. (2016) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20160055 · Cited by 51
Amara, W., Montagnier, C., Cheggour, S., Boursier, M., Gully, C., BARNAY, C., Georger, F., Deplagne, A., Fromentin, S., Młotek, M., et al. (2017) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.13062 · Cited by 49
Refinement of Ischemic Stroke Risk in Patients with Atrial Fibrillation and CHA2DS2‐VASc Score of 1
Huang, D., ANGUO, L., Yue, W., Yin, L., Tse, H., & Siu, C. (2014) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.12445 · Cited by 48
Detection of Atrial Fibrillation in Cryptogenic Stroke
Hæusler, K. G., Tütüncü, S., & Schnabel, R. B. (2018) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-018-0871-1 · Cited by 49
Lip, G. Y. H., Al‐Khatib, S. M., Cosío, F. G., Banerjee, A., Savelieva, I., Ruskin, J. N., Blendea, D. C., Nattel, S., Bono, J. D., Conroy, J., et al. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.114.001179 · Cited by 48
Self-citationStroke and Bleeding Risk in Atrial Fibrillation
Senoo, K., Lane, D. A., & Lip, G. Y. H. (2014) · Korean Circulation Journal · doi:10.4070/kcj.2014.44.5.281 · Cited by 46
Self-citationForslund, T., Wettermark, B., Wändell, P. E., von Euler, M., Hasselström, J., & Hjemdahl, P. (2014) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-014-1739-1 · Cited by 46
Allan, V., Banerjee, A., Shah, A. D., Patel, R. S., Denaxas, S., Casas, J. P., & Hemingway, H. (2016) · Heart · doi:10.1136/heartjnl-2016-309910 · Cited by 45
2025 Clinical practice guidelines for Atrial fibrillation and flutter
Golukhova, E. Z., Sp, G., Михайлов, Е. Н., Revishvili, A. S. H., Arakelyan, M. G., Vasilyeva, E. Y., Davtyan, K. V., Drapkina, O. M., Drozdova, L. Y., Станиславовна, К. Е., et al. (2026) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2025-6668 · Cited by 44
Lee, S., Uhm, J., Kim, J., Pak, H., Lee, M., & Joung, B. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.11.183 · Cited by 43
Lip, G. Y. H., Lin, H., Hsu, H., Su, T., Chen, M.-F., Lee, Y., & Chien, K. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.12.076 · Cited by 43
Self-citationClinical and Pharmacological Effects of Apixaban Dose Adjustment in the ARISTOTLE Trial
Zeitouni, M., Giczewska, A., Lópes, R. D., WOJDYLA, D. M., Christersson, C., Siegbahn, A., Caterina, R. D., Steg, P. G., Granger, C. B., Wallentin, L. C., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.12.060 · Cited by 43
Metadata
- Authors
- Friberg, L., Rosenqvist, M., & Lip, G. Y. H.
- Affiliations
- Birmingham City Hospital (GB)
- Danderyds sjukhus (SE)
- Venue
- Circulation
- Published
- 2012-05-15
- Volume
- 125
- Issue
- 19
- Pages
- 2298-2307
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2165762371
- Cited by
- 454
- References
- 38
- Citations by year
- 2026: 9 · 2025: 15 · 2024: 9 · 2023: 14 · 2022: 16 · 2021: 28 · 2020: 31 · 2019: 33 · 2018: 26 · 2017: 30 · 2016: 57 · 2015: 50 · 2014: 54 · 2013: 57 · 2012: 24
- FWCI
- 38.08
- Type
- journal article
- Language
- en
- Open access
- Licence
- other-oa
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
- Keywords
- atrial fibrillation, warfarin, anticoagulation, net clinical benefit, ischemic stroke, intracranial hemorrhage, CHA2DS2-VASc score, CHADS2 score, stroke risk stratification, bleeding risk, hospital discharge registry
- MeSH terms
- Aged, Anticoagulants, Atrial Fibrillation, Cerebral Hemorrhage, Female, Follow-Up Studies, Humans, Male, Middle Aged, Registries, Risk Factors, Sweden, Warfarin, Cohort Studies, Incidence, Stroke, Intracranial Embolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
